News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
480,862 Results
Type
Article (28242)
Company Profile (82)
Press Release (452538)
Section
Business (145718)
Career Advice (801)
Deals (24757)
Drug Delivery (44)
Drug Development (54942)
Employer Resources (67)
FDA (13130)
Job Trends (10440)
News (243685)
Policy (22790)
Tag
Academia (1833)
Africa (465)
Alliances (33419)
Alzheimer's disease (759)
Approvals (13099)
Arizona (96)
Artificial intelligence (55)
Asia (28518)
Australia (4407)
Bankruptcy (201)
Best Places to Work (8112)
Biotechnology (62)
Breast cancer (54)
C2C Services and Suppliers (66557)
California (1398)
Canada (727)
Cancer (432)
Career advice (703)
Cell therapy (89)
China (112)
Clinical research (44533)
Collaboration (115)
Colorado (56)
Compensation (47)
Connecticut (61)
COVID-19 (1535)
Data (373)
Diabetes (65)
Diagnostics (4255)
Drug pricing (44)
Earnings (57475)
Employer resources (63)
Europe (58304)
Events (71815)
Executive appointments (148)
FDA (13378)
Florida (223)
Funding (115)
Gene therapy (46)
GLP-1 (327)
Government (3116)
Healthcare (14327)
Hotbed/Location (332824)
Idaho (44)
Illinois (205)
Indiana (118)
Infectious disease (1555)
Inflammatory bowel disease (72)
Interviews (81)
IPO (11287)
Job creations (2473)
Job search strategy (651)
Kansas (74)
Layoffs (210)
Legal (4905)
Liver cancer (47)
Lung cancer (92)
Maine (51)
Maryland (353)
Massachusetts (1070)
Medical device (12963)
Medtech (12967)
Mergers & acquisitions (13438)
Metabolic disorders (185)
Michigan (89)
Minnesota (198)
Neuroscience (877)
New Hampshire (49)
New Jersey (499)
New York (477)
NextGen Class of 2024 (4666)
Non-profit (3158)
North Carolina (467)
Northern California (649)
Obesity (115)
Ohio (78)
Opinion (79)
Pennsylvania (437)
People (44574)
Phase I (12965)
Phase II (19387)
Phase III (15590)
Pipeline (117)
Postmarket research (1881)
Preclinical (4503)
Press Release (68)
Radiopharmaceuticals (181)
Rare diseases (81)
Real estate (3900)
Regulatory (15520)
Research institute (1710)
Resumes & cover letters (104)
South America (690)
Southern California (586)
Startups (2494)
Texas (198)
United States (6553)
Vaccines (263)
Washington State (117)
Weight loss (91)
Date
Today (105)
Last 7 days (461)
Last 30 days (1955)
Last 365 days (26466)
2024 (19422)
2023 (29137)
2022 (38629)
2021 (41595)
2020 (40402)
2019 (34391)
2018 (26301)
2017 (23636)
2016 (22615)
2015 (27196)
2014 (20976)
2013 (17425)
2012 (18752)
2011 (19342)
2010 (18207)
480,862 Results for "apyx medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit.
April 11, 2024
·
3 min read
Business
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
April 25, 2024
·
2 min read
Business
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
Apyx Medical Corporation today reported financial results for its first quarter ended March 31, 2024; and reaffirmed its financial expectations for the full year ending December 31, 2024.
May 9, 2024
·
13 min read
Business
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the fourth quarter and fiscal year 2023 will be released before the market opens on Thursday, March 21st.
March 4, 2024
·
1 min read
Business
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Apyx Medical Corporation today reported financial results for its fourth quarter and full year ended December 31, 2023.
March 21, 2024
·
16 min read
Business
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
Apyx Medical Corporation today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023.
November 28, 2023
·
5 min read
Business
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
Apyx Medical Corporation, the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, reported preliminary revenue results for the fourth quarter and full year ended December 31, 2023.
January 8, 2024
·
5 min read
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
Apyx Medical Corporation today announced that the Company and its subsidiaries have entered into a new, five-year credit agreement with Perceptive Credit Holdings IV, LP (“Perceptive”), an affiliate of Perceptive Advisors.
November 9, 2023
·
6 min read
Business
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
Apyx Medical Corporation reported financial results for its third quarter ended September 30, 2023, and updated its financial expectations for the full year ending December 31, 2023.
November 9, 2023
·
17 min read
Business
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
Apyx ® Medical Corporation today announced that financial results for the third quarter of fiscal year 2023 will be released before the market opens on Thursday, November 9th.
October 2, 2023
·
1 min read
1 of 48,087
Next
